Marty Makary resigns as FDA commissioner after internal tensions

SITREP: Marty Makary has resigned from his position as FDA Commissioner following reports of internal tensions within the agency. His departure comes amid speculation regarding the future of his tenure. TACTICAL ASSESSMENT: This resignation may indicate ongoing instability within the FDA, potentially impacting its regulatory processes and public health initiatives. The change in leadership could lead to shifts in policy direction and priorities at the agency. PROJECTED VECTORS: The FDA may experience further leadership changes or policy adjustments in response to this resignation.